RT Journal Article
SR Electronic
T1 Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP P272
DO 10.1186/2051-1426-1-S1-P272
VO 1
IS Suppl 1
A1 Sabado, Rachel L
A1 Pavlick, Anna
A1 Gnjatic, Sacha
A1 Cruz, Crystal
A1 Vengco, Isabelita
A1 Hasan, Farah
A1 Darvishian, Farbod
A1 Chiriboga, Luis
A1 Holman, Rose Marie
A1 Escalon, Juliet
A1 Muren, Caroline
A1 Escano, Crystal
A1 Yepes, Ethel
A1 Sharpe, Dunbar
A1 Adams, Sylvia
A1 Ott, Patrick
A1 Jungbluth, Achim
A1 Pan, Linda
A1 Venhaus, Ralph
A1 Bhardwaj, Nina
YR 2013
UL http://jitc.bmj.com/content/1/Suppl_1/P272.abstract